Randomized Clinical Trial: The Clinical Effects of Herb-Partitioned Moxibustion in Patients with Diarrhoea-Predominant Irritable Bowel Syndrome

Table 3

Changes of GSRS total score in the three groups.

	Baseline (week 0); (mean ± S.E.)	Week 4; (mean ± S.E.)	Change at; week 4	𝑃 value	Week 8; (mean ± S.E.)	Change at; week 8	𝑃 value
Group HM	8.75±0.251	1.98±0.303	−6.77^∆	<0.01	2.75±0.306	−6.00^#	<0.01
Group FM	8.60±0.276	2.93±0.302	−5.67	<0.01	3.56±0.329^∗	−5.04	<0.01
Group PB	8.85±0.287	3.73±0.449	−5.12	<0.01	4.39±0.482^∗∗	−4.46	<0.01

S.E.: standard error; compared with week 4, ^∗𝑃<0.01, ^∗∗𝑃<0.05; compared with Group PB, ^▵𝑃<0.01, ^#𝑃<0.01; GSRS: gastrointestinal symptom rating scale; HM: herb-partitioned moxibustion; FM: farina-partitioned moxibustion; PB: orally taking pinaverium bromide.